Kidney function and multiple hemostatic markers: Cross sectional associations in the multi-ethnic study of atherosclerosis

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Dubin, Ruth ^a   Cushman, Mary ^b   Folsom, Aaron R ^c   Fried, Linda F ^d   Palmas, Walter ^e   Peralta, Carmen A ^a,d   Wassel, Christina ^f   Shlipak, Michael G ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c Division of Epidemiology   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; D DIMER; FIBRINOGEN; PLASMIN; THROMBOMODULIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE MARKER; ETHNIC DIFFERENCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMOSTASIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; BLOOD; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS; UNITED STATES;

BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; UNITED STATES;

EID: 79251553148     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-3     Document Type: Article

References (44)

1. Definition and Classification of Stages of Chronic Kidney Disease. KDOQI, 2002 http://www.kidney.org/professionals/kdoqi/guidelines-ckd/p4-class-g2.htm
2. Evidence for increased cardiovascular disease risk in patients with chroni (Pubitemid 39069902)
3. Chronic kidney disease: effects on the cardiovascular system. EL Schiffrin ML Lipman JF Mann, Circulation 2007 116 1 85 97 (Pubitemid 47016250)
4. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. MG Shlipak R Katz MJ Sarnak LF Fried AB Newman C Stehman-Breen,, et al. Ann Intern Med 2006 145 4 237 46 (Pubitemid 46768607)
5. Cystatin C and the risk of death and cardiovascular events among elderly persons. MG Shlipak MJ Sarnak R Katz LF Fried SL Seliger AB Newman,, et al. N Engl J Med 2005 352 20 2049 60 (Pubitemid 40664306)
6. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. MG Shlipak CL Wassel Fyr GM Chertow TB Harris SB Kritchevsky FA Tylavsky,, et al. J Am Soc Nephrol 2006 17 1 254 61
7. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? P Stenvinkel JJ Carrero J Axelsson B Lindholm O Heimburger Z Massy, Clin J Am Soc Nephrol 2008 3 2 505 21
8. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. AK Cheung MJ Sarnak G Yan JT Dwyer RJ Heyka MV Rocco,, et al. Kidney Int 2000 58 1 353 62 (Pubitemid 30429882)
9. Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable. ZA Massy P Taupin P Jungers P Landais, Prilozi 2005 26 2 63 77
10. Factors associated with mortality in patients new to haemodialysis. DM Spiegel P Raggi G Smits GA Block, Nephrol Dial Transplant 2007 22 12 3568 72 (Pubitemid 350212490)
11. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. FA Hellenthal WA Buurman WK Wodzig GW Schurink, Nat Rev Cardiol 2009 6 7 464 74
12. Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. MG Shlipak LF Fried C Stehman-Breen D Siscovick AB Newman, Am J Geriatr Cardiol 2004 13 2 81 90
13. Cystatin-C and inflammatory markers in the ambulatory elderly. MG Shlipak R Katz M Cushman MJ Sarnak C Stehman-Breen BM Psaty,, et al. Am J Med 2005 118 12 1416
14. Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. C Keller R Katz MJ Sarnak LF Fried B Kestenbaum M Cushman,, et al. Nephrol Dial Transplant 2010 25 1 119 24
15. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. CR Keller MC Odden LF Fried AB Newman S Angleman CA Green,, et al. Kidney Int 2007 71 3 239 44 (Pubitemid 46160924)
16. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. D Singh MA Whooley JH Ix S Ali MG Shlipak, Nephrol Dial Transplant 2007 22 4 1087 92 (Pubitemid 46523422)
17. Multi-ethnic study of atherosclerosis: objectives and design. DE Bild DA Bluemke GL Burke R Detrano AV Diez Roux AR Folsom,, et al. Am J Epidemiol 2002 156 9 871 81 (Pubitemid 35215769)
18. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. LA Stevens J Coresh CH Schmid HI Feldman M Froissart J Kusek,, et al. Am J Kidney Dis 2008 51 3 395 406 (Pubitemid 351273480)
19. Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. K Murthy LA Stevens PC Stark AS Levey, Kidney Int 2005 68 4 1884 7 (Pubitemid 43169935)
20. A new equation to estimate glomerular filtration rate. AS Levey LA Stevens CH Schmid YL Zhang AF Castro HI Feldman,, et al. Ann Intern Med 2009 150 9 604 12
21. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. PJ Declerck MC Alessi M Verstreken EK Kruithof I Juhan-Vague D Collen, Blood 1988 71 1 220 5 (Pubitemid 18050415)
22. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr,, et al. JAMA 2003 289 19 2560 72 (Pubitemid 37430158)
23. Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats. M Nakano M Furutani H Shinno T Ikeda K Oida H Ishii, Thromb Res 2000 99 1 83 91 (Pubitemid 30440744)
24. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. SH Jacobson N Egberg B Hylander J Lundahl, Am J Nephrol 2002 22 1 42 7 (Pubitemid 34264185)
25. Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure. D Mezzano R Tagle E Pais O Panes M Perez P Downey,, et al. Thromb Res 1997 88 6 465 72 (Pubitemid 28219053)
26. Soluble thrombomodulin and coronary heart disease. KK Wu, Curr Opin Lipidol 2003 14 4 373 5 (Pubitemid 36951903)
27. Tissue factor and cardiovascular disease. A Breitenstein FC Tanner TF Luscher, Circ J 2010 74 1 3 12
28. Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease. V Toschi, J Thromb Haemost 2007 5 3 472 4 (Pubitemid 46690901)
29. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. MJ Adams AB Irish GF Watts R Oostryck GK Dogra, Thromb Res 2008 123 2 374 80
30. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. PE Morange S Blankenberg MC Alessi C Bickel HJ Rupprecht R Schnabel,, et al. J Thromb Haemost 2007 5 3 475 82 (Pubitemid 46680678)
31. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. AR Folsom N Aleksic E Park V Salomaa H Juneja KK Wu, Arterioscler Thromb Vasc Biol 2001 21 4 611 7 (Pubitemid 32323396)
32. Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. SG Wannamethee AG Shaper GD Lowe L Lennon A Rumley PH Whincup, Eur Heart J 2006 27 24 2975 81 (Pubitemid 44950441)
33. von Willebrand factor: a marker of endothelial damage? PM Mannucci, Arterioscler Thromb Vasc Biol 1998 18 9 1359 62 (Pubitemid 28421871)
34. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. J Danesh JG Wheeler GM Hirschfield S Eda G Eiriksdottir A Rumley,, et al. N Engl J Med 2004 350 14 1387 97 (Pubitemid 38419992)
35. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. A Rumley GD Lowe PM Sweetnam JW Yarnell RP Ford, Br J Haematol 1999 105 1 110 6 (Pubitemid 29197151)
36. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. LD Bash TP Erlinger J Coresh J Marsh-Manzi AR Folsom BC Astor, Am J Kidney Dis 2009 53 4 596 605
37. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. AR Folsom JA Delaney PL Lutsey NA Zakai NS Jenny JF Polak,, et al. Am J Hematol 2009 84 6 349 53
38. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. PE Morange C Bickel V Nicaud R Schnabel HJ Rupprecht D Peetz,, et al. Arterioscler Thromb Vasc Biol 2006 26 12 2793 9
39. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. M Cushman RN Lemaitre LH Kuller BM Psaty EM Macy AR Sharrett,, et al. Arterioscler Thromb Vasc Biol 1999 19 3 493 8 (Pubitemid 29135146)
40. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. S Shrivastava PM Ridker RJ Glynn SZ Goldhaber S Moll H Bounameaux,, et al. J Thromb Haemost 2006 4 6 1208 14
41. Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. K Wattanakit M Cushman, Curr Opin Pulm Med 2009 15 5 408 12
42. Chronic kidney disease and venous thromboembolism: a prospective study. AR Folsom PL Lutsey BC Astor K Wattanakit SR Heckbert M Cushman, Nephrol Dial Transplant 2010
43. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. H Ishii M Nakano J Tsubouchi T Ishikawa H Uchiyama S Hiraishi,, et al. Thromb Haemost 1990 63 2 157 62 (Pubitemid 20128174)
44. Development and validation of an assay for urinary tissue factor activity. BA Lwaleed M Chisholm JL Francis, J Clin Pathol 1999 52 3 219 24 (Pubitemid 29125416)